0001209191-18-011401.txt : 20180220 0001209191-18-011401.hdr.sgml : 20180220 20180220170052 ACCESSION NUMBER: 0001209191-18-011401 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180217 FILED AS OF DATE: 20180220 DATE AS OF CHANGE: 20180220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alles Mark J CENTRAL INDEX KEY: 0001538897 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 18625527 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-17 0 0000816284 CELGENE CORP /DE/ CELG 0001538897 Alles Mark J C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 1 1 0 0 See Remarks Common Stock 2018-02-17 4 M 0 7283 0.00 A 186187 D Common Stock 2018-02-17 4 F 0 2060 95.26 D 184127 D Common Stock 5924 I 401(k) Plan Performance Stock Unit 2018-02-17 4 M 0 7283 0.00 D Common Stock 7283 0 D The performance stock units granted to the reporting person on February 13, 2018 vested and settled for shares of the Company's common stock. Each performance stock unit represents a contingent right to receive one share of the Company's common stock. The performance stock units were issued pursuant to the Company's 2017 Stock Incentive Plan. Chief Executive Officer /s/ Peter N. Kellogg, Attorney-in-Fact 2018-02-20